Royal Bank of Canada’s HilleVax HLVX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-805
| Closed | -$2K | – | 7284 |
|
|
2025
Q2 | $2K | Sell |
805
-810
| -50% | -$1.48K | ﹤0.01% | 6795 |
|
|
2025
Q1 | $2K | Sell |
1,615
-4,524
| -74% | -$8.36K | ﹤0.01% | 6566 |
|
|
2024
Q4 | $13K | Buy |
6,139
+3,148
| +105% | +$5.91K | ﹤0.01% | 6269 |
|
|
2024
Q3 | $5K | Sell |
2,991
-2,706
| -47% | -$6.94K | ﹤0.01% | 6497 |
|
|
2024
Q2 | $83K | Buy |
5,697
+2,375
| +71% | +$32.6K | ﹤0.01% | 5375 |
|
|
2024
Q1 | $55K | Sell |
3,322
-8,770
| -73% | -$140K | ﹤0.01% | 5499 |
|
|
2023
Q4 | $195K | Buy |
12,092
+5,524
| +84% | +$73.4K | ﹤0.01% | 5121 |
|
|
2023
Q3 | $89K | Buy |
6,568
+1,789
| +37% | +$25.2K | ﹤0.01% | 5455 |
|
|
2023
Q2 | $82K | Buy |
4,779
+1,072
| +29% | +$16.6K | ﹤0.01% | 5475 |
|
|
2023
Q1 | $61K | Sell |
3,707
-1,451
| -28% | -$23.2K | ﹤0.01% | 5514 |
|
|
2022
Q4 | $87K | Buy |
5,158
+5,000
| +3,165% | +$90.3K | ﹤0.01% | 5554 |
|
|
2022
Q3 | $3K | Buy |
158
+85
| +116% | +$1.24K | ﹤0.01% | 6892 |
|
|
2022
Q2 | $1K | Buy |
+73
| New | +$867 | ﹤0.01% | 7127 |
|
Royal Bank of Canada's HLVX Position: Q3 2025 in Review
Royal Bank of Canada sold out of HilleVax (HLVX) in Q3 2025, closing a stake of 805 shares — an estimated $2K sold.
Royal Bank of Canada first reported a position in HLVX in Q2 2022 and held it in 13 quarters. The position peaked at $195K in Q4 2023. 1 fund tracked by Wall St. Rank holds HLVX as of Q3 2025.
- Royal Bank of Canada reported no remaining HilleVax position as of Q3 2025 after selling out during the quarter.
- Royal Bank of Canada sold 805 HilleVax shares in Q3 2025, an estimated $2K.
- Royal Bank of Canada first reported a position in HilleVax in Q2 2022 and held it in 13 quarters.
- Royal Bank of Canada's HilleVax position peaked at $195K in Q4 2023.
- 1 fund tracked by Wall St. Rank held HilleVax as of Q3 2025.
Based on Royal Bank of Canada's 13F filing for Q3 2025, filed 14 Nov 2025.